Lindsay Frazier

Comparison of overall and patterns of care in patients with a malignant ovarian germ cell tumor by age in the United States: a National Cancer Database (2004-2016) analysis.

Sullivan SM, Stoneham S, Lockley M, Frazier AL, Billmire DF, Poynter JN.

Int J Gynecol Cancer. 2024 Jul 01. PMID: 38955375

Outcomes in ovarian Sertoli-Leydig cell tumor: A report from the International Pleuropulmonary Blastoma/DICER1 and Ovarian and Testicular Stromal Tumor Registries.

Nelson AT, Harris AK, Watson D, Kamihara J, Chen KS, Stall JN, Devins KM, Young RH, Olson DR, Mallinger PHR, Mitchell SG, Hoffman LM, Halliday G, Suleymanova AM, Glade Bender JL, Messinger YH, Herzog CE, Field AL, Frazier AL, Stewart DR, Dehner LP, Hill DA, Billmire DF, Schneider DT, Schultz KAP.

Gynecol Oncol. 2024 Jul. 186:117-125. PMID: 38657450

Consensus and controversy in the management of paediatric and adult patients with ovarian immature teratoma: the Malignant Germ Cell International Consortium perspective.

Pashankar F, Murray MJ, Gell J, MacDonald N, Shamash J, Billmire DF, Klosterkemper L, Olson T, Hirsch MS, Lockley M, Stoneham S, Frazier AL.

EClinicalMedicine. 2024 Mar. 69:102453. PMID: 38544795

Incidence and survival for childhood cancer by endorsed non-stage prognostic indicators in Australia.

Youlden DR, Gupta S, Frazier AL, Moore AS, Gottardo NG, Aitken JF.

Pediatr Blood Cancer. 2024 Apr. 71(4):e30889. PMID: 38265260

Comment on "Comment on 'A Nested Case-Control Study of Serum Per- and Polyfluoroalkyl Substances and Testicular Germ Cell Tumors among U.S. Air Force Servicemen'".

Shioda T, Weiss RS, Bagrodia A, Frazier AL.

Environ Health Perspect. 2023 Dec. 131(12):128001. PMID: 38099920

Adolescent and Young Adult Germ Cell Tumors: Epidemiology, Genomics, Treatment, and Survivorship.

Travis LB, Feldman DR, Fung C, Poynter JN, Lockley M, Frazier AL.

J Clin Oncol. 2024 Feb 20. 42(6):696-706. PMID: 37820296

Evaluation of prevalence and outcomes of serial tyrosine kinase inhibitor use in pediatric patients with advanced solid tumors.

Olsen HE, Liu KX, Frazier AL, O'Neill AF, Janeway KA, DuBois SG, Shulman DS.

Pediatr Blood Cancer. 2023 11. 70(11):e30652. PMID: 37644664

Characterizing Lymphovascular Invasion in Pediatric and Adolescent Malignant Ovarian Nongerminomatous Germ Cell Tumors: A Report from the Children's Oncology Group.

Rich BS, Dicken BJ, Billmire DF, Weil BR, Ross J, Fallahazad N, Krailo M, Shaikh F, Frazier AL, Hazard FK, Nuño MM.

J Pediatr Surg. 2023 Dec. 58(12):2399-2404. PMID: 37699777

Children's Oncology Group's 2023 blueprint for research: Germ cell tumors.

Bhuta R, Shah R, Gell JJ, Poynter JN, Bagrodia A, Dicken BJ, Pashankar F, Frazier AL, Shaikh F.

Pediatr Blood Cancer. 2023 09. 70 Suppl 6:e30562. PMID: 37449938

Refining the serum miR-371a-3p test for viable germ cell tumor detection.

Lafin JT, Scarpini CG, Amini A, Konneh B, Howard JM, Gerald T, Nuno M, Piao J, Savelyeva A, Wang Z, Gagan J, Jia L, Lewis CM, Murray S, Sawa YC, Margulis V, Woldu SL, Strand DW, Coleman N, Amatruda JF, Frazier AL, Murray MJ, Bagrodia A.

Sci Rep. 2023 06 29. 13(1):10558. PMID: 37386046